Study of testosterone in older men

November 12, 2009

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center announced today that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, decreased vitality, impaired memory and sexual function, loss of muscle mass and other health conditions that affect older men.

"LA BioMed is pleased to be chosen as the only site in Los Angeles and one of 12 sites in the country for this national study of the effectiveness of in the treatment of health problems that affect with low testosterone levels," said Ronald S. Swerdloff, MD, principal investigator for the study at LA BioMed. "We may be able to help older men with low testosterone levels remain healthy and independent longer if we find testosterone to be an effective treatment for health problems associated with low testosterone levels."

Funded primarily by the National Institute on Aging (NIA) and coordinated by the University of Pennsylvania School of Medicine, the Testosterone Trial will involve 800 men at 12 sites around the country. About 70 volunteers are expected to participate in the study at LA BioMed.

The Testosterone Trial will include five separate studies. Men, ages 65 and older, with low testosterone and at least one of the following conditions - anemia, decreased physical function, low vitality, impaired cognition or reduced - will be randomly assigned to participate in a treatment group or a control group.

Treatment groups will be given a testosterone gel that is applied to the torso, abdomen or upper arms, while men in the control groups will receive a placebo gel for application to the same areas of their bodies.

Serum testosterone will be measured monthly for the first three months, and quarterly thereafter, for up to one year. Participants will be tested on a wide range of measures to evaluate physical function, vitality, cognition, cardiovascular disease and sexual function. A non-invasive method of checking for coronary obstruction will be performed before and after treatment on those that qualify.

"This study is important because testosterone products have been marketed for many years as treatments for a variety of conditions," said Evan C. Hadley, MD, director of NIA's Division of Geriatrics and Clinical Gerontology. "We hope this trial will establish whether testosterone therapy results in clear benefits for older men."

More information: More information about the study and criteria for participation is available at: … terone+aging&rank=40 .

Source: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

Related Stories

Recommended for you

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

New breast cell types discovered by multidisciplinary research team

November 20, 2017
A joint effort by breast cancer researchers and bioinformaticians has provided new insights into the molecular changes that drive breast development.

Brain cell advance brings hope for Creutzfeldt-Jakob disease

November 20, 2017
Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Age and gut bacteria contribute to multiple sclerosis disease progression

November 17, 2017
Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS) disease onset and progression.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Nov 12, 2009
I would like to know if they are using bio-identical hormone for this study.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.